Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology - 1 Sept 2009

Cao Xin-xian, Li Jia, Qiu Long-min, Luo Ya-wen, Chen Ying-hua, Ran Yan

Abstract excerpt

OBJECTIVE: To identify factors associated with YMDD mutation in patients with chronic hepatitis B before and after lamivudine treatment in Zunyi region. METHODS: 53 patients with chronic hepatitis B were enrolled in this study, HBV DNA,HBV markers, ALT, AST, TBil, albumin in the serum were examined at 0, 3, 6, 12, 18 and 24 months after lamivudine treatment. HBV genotype and YMDD mutation were determined by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aspartate Aminotransferases

Share to DNA, Viral

Share to Drug Resistance, Viral

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to Lamivudine

Source

Identifiers

PMID: 19785947

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].PMID 19785947Read ↗

Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment.Semantic proximity Read ↗

[Efficacy changes of short-term lamivudine therapy for chronic hepatitis B with emergence of YMDD mutation].Semantic proximity Read ↗

[Types and emergence time of YMDD motif mutation in hepatitis B virus polymerase gene during lamivudine treatment].Semantic proximity Read ↗

[A study on the treatment of chronic hepatitis B with YMDD mutation].Semantic proximity Read ↗

[Emergence and clinical significance of YMDD and HBeAg-related mutations during lamivudine treatment].Semantic proximity Read ↗

[Natural YMDD motif mutations of HBV polymerase in the chronic hepatitis B virus infected patients].Semantic proximity Read ↗

Clinical features of chronic hepatitis B patients with YMDD mutation after lamivudine therapy.Semantic proximity Read ↗

[Occurrence and predictive factors of hepatitis B virus polymerase YMDD variation among patients with chronic hepatitis B and liver cirrhosis during lamivudine therapy].Semantic proximity Read ↗

[The mutation patterns of HBV P gene and genotyping in patients with lanivudine-resistant chronic hepatitis B].Semantic proximity Read ↗

[Relationship between B virus hepatitis genotypes and therapeutic efficacy in early treatment for chronic hepatitis B by using lamivudine].Semantic proximity Read ↗

Interferon-α combined with lamivudine versus lamivudine monotherapy for the emergence of YMDD mutations in chronic hepatitis B infection: a meta-analysis of randomized controlled trials.Semantic proximity Read ↗

[A study on the mutation of P gene region including YMDD motif in hepatitis B virus].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.